Colorectal Cancer clinical trials in Rhode Island

6 actively recruiting colorectal cancer trials at 1 site across Rhode Island.

Data from ClinicalTrials.gov · last refreshed 2026-08-17

Phase 2 Recruiting Academic/Other

Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

BrUOG-430 is a prospective, single-arm, phase 2 trial evaluating yttrium-90 radioembolization in combination with capecitabine and atezolizumab for the treatment of unresectable colorectal cancer liver metastases in individuals who have be…

Sponsor: Brown University

NCT ID: NCT06555133

Sites in Rhode Island:

Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals Providence, Rhode Island, United States, 02903 Contact: — Providence, Rhode Island

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

The investigational drug to be studied in this protocol, BCA101, is a first-in-class compound that targets both EGFR with TGFβ. Based on preclinical data, this bifunctional antibody may exert synergistic activity in patients with EGFR-driv…

Sponsor: Bicara Therapeutics

NCT ID: NCT04429542

Sites in Rhode Island:

Rhode Island Hospital — Providence, Rhode Island

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Rhode Island:

Providence Veterans Administration Hospital — Providence, Rhode Island

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

This trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to participants randomized to surveillance colonoscopy at 5 and 10 years.

Sponsor: NRG Oncology

NCT ID: NCT05080673

Sites in Rhode Island:

Providence Veterans Administration Hospital — Providence, Rhode Island

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in Rhode Island:

Massive Bio SYNERGY-AI site — Providence, Rhode Island

View on ClinicalTrials.gov →

NA Recruiting Industry

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.

Sponsor: Colospan Ltd.

NCT ID: NCT04184973

Sites in Rhode Island:

Lifespan & Brown Surgical Associates — Providence, Rhode Island

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-08-17